A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

BACKGROUND: Secondary hyperparathyroidism may lead to increased cardiovascular risk. The use of cinacalcet may improve bone and cardiovascular health with improved parathormone (PTH) and phosphate control. METHODS: This is an open-label prospective randomised controlled trial to compare progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Eddington, Helen, Chinnadurai, Rajkumar, Alderson, Helen, Ibrahim, Sara T., Chrysochou, Constantina, Green, Darren, Erekosima, Ibi, Hutchison, Alastair, Bubtana, Abdalla, Hegarty, Janet, Kalra, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989372/
https://www.ncbi.nlm.nih.gov/pubmed/33757437
http://dx.doi.org/10.1186/s12882-021-02312-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989372/
https://www.ncbi.nlm.nih.gov/pubmed/33757437
http://dx.doi.org/10.1186/s12882-021-02312-2

Ejemplares similares